老虎证券

美股详情
本页面由Tiger Trade Technology Pte. Ltd.提供服务

Can-Fite Biopharma Ltd

3.00
-0.0150-0.50%
成交量：2.87万
成交额：8.62万
市值：641.69万
市盈率：0.00
高：3.05
开：2.96
低：2.95
收：3.01
52周最高：36.40
52周最低：2.95
股本：214.25万
流通股本：210.50万
量比：2.25
换手率：1.36%
股息：- -
股息率：- -
每股收益(TTM):-1,791.0249
每股收益(LYR):-3,259.3317
净资产收益率：-178.24%
总资产收益率：-66.75%
市净率：1.15
市盈率(LYR):0.00

数据加载中...

总览公司新闻资讯公告
2020/04/06

SEC问询函

CORRESP [Cover] - Correspondence
2020/04/06

SEC问询函

CORRESP [Cover] - Correspondence
2020/04/02

非美公司披露报告

6-K/A [Amend] - Report of foreign issuer [Rules 13a-16 and 15d-16]
2020/04/01

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2020/03/30

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2020/03/27

招股说明书

F-1 - Registration statement for certain foreign private issuers
2020/03/27

年度报告

20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]
2020/03/27

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2020/03/23

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2020/03/18

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2020/03/16

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2020/03/13

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2020/03/11

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2020/03/09

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2020/03/05

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2020/03/03

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2020/02/27

非美公司披露报告

6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
2020/02/24

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2020/02/20

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2020/02/20

超过5%披露

Statement of acquisition of beneficial ownership by individuals
更多